[Clinical evaluation of the hypotensive effects of nadolol].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol
Ocena hipotensyjnego działania nadololu.